/ /

  • linkedin
  • Increase Font
  • Sharebar

    Roles of Klotho and Endothelin-1 in pseudoexfoliation


    The researchers found that the mean serum level of Klotho was 50.49 ng/mL in the PEG group, 56.32 ng/mL in the PXF group, and 65.06 ng/mL in the control group. The mean aqueous level of Klotho was 34.53 ng/mL in the PEG group, 49.02 ng/mL in the PXF group, and 56.31 ng/mL in the control group.

    These differences between PEG on one hand and PXF and control for both serum and aqueous levels were statistically significant (P = 0.001-0.003). Likewise, the comparisons between PXF and control was significant (P = 0.006 for aqueous and 0.004 for serum).

    The mean serum level of ET-1 was 1.66 pg/mL in the PXF patients, 1.58 in the PEG patients and 1.16 pg/mL in the control patients. The mean aqueous level of ET-1 was 1.45 in the PEG patients, 1.28 pg/mL in the PXF patients, and 1.17 pg/mL in the control group.

    The serum and aqueous ET-1 difference between the PXF group and the control group, and between the PEG group and the control group were both statistically significant (P = 0.01). The difference in serum ET-1 levels was not significant between the PEG and PXF groups. However, the difference in aqueous ET-1 levels was significant between the PEG and PXF groups (P = 0.04).

    The researchers also found a negative correlation between the aqueous levels of Klotho and the severity of PXF (correlation coefficient [CC] = -0.68, P = 0.01). They did not find any correlation between the severity of PXF and ET-1 aqueous levels (CC = 0.05, P = 0.86).

    Using cup-to-disc ratio, they found a negative correlation between the severity of glaucoma and aqueous Klotho levels (CC = -0.57, P = 0.01) and a positive correlation between aqueous ET-1 and the severity of glaucoma (CC = 0.55, P = 0.01).

    The finding fits well into the pattern of previous research. Studies have found that Klotho protects against cardiovascular and renal disease, perhaps due to its antioxidant effect. It appears to play a role in preventing age-related macular degeneration, and to protect retinal pigmented epithelium cells.

    Other researchers have reported that levels of ET-1, and the numbers of endothelin A and endothelin B receptors increased dramatically in patients with normal tension glaucoma. They have found that plasma levels of ET-1 significantly increase in patients with progressive open-angle glaucoma.

    Ahoor and colleagues acknowledged some limitations of their study. First, all the patients had senile cataract, which might affect Klotho levels. They tried to minimize this potentially confounding factor by selecting patients with the same grade of cataract for all groups. Still, total Klotho levels might be underestimated in all these groups, they pointed out.

    Second, the study had small sample sizes and its cross-sectional design prevented it from showing whether serum and aqueous Klotho and ET-1 concentrations were predictive for the progression of PXF and PEG.

    They called for further research aimed at determining the potential of Klotho to protect against PXF and PEG. 

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results